Through the Correct Lens: Understanding Overprescription of Stimulant Drugs, Their Abuse, and Where the Remedies Lie

DSpace/Manakin Repository

Through the Correct Lens: Understanding Overprescription of Stimulant Drugs, Their Abuse, and Where the Remedies Lie

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Lombardo, Marguerite R. en_US
dc.date.accessioned 2012-06-15T20:14:59Z
dc.date.issued 2004 en_US
dc.identifier.citation Through the Correct Lens: Understanding Overprescription of Stimulant Drugs, Their Abuse, and Where the Remedies Lie (2004 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889428
dc.description.abstract This paper argues that stimulant drugs, such as Ritalin and Adderall, are overprescribed for the treatment of Attention-Deficit/Hyperactivity Disorder. Overprescription is viewed through a physician-centered lens. That is, physicians overprescribe stimulant drugs to the extent they inadequately evaluate a patient before prescribing. The physician-centered approach contrasts sharply with a patient-centered approach which defines as overprescription the extent to which stimulant drug prescription rates exceed the actual prevalence of ADHD. Overprescription is important to address because it contributes to stimulant drug abuse among young adults. Legitimate patients with valid prescriptions, particularly on college campuses, are giving away or selling their stimulant medication to their peers. Overprescription contributes to this problem by unnecessarily inflating the number of prescriptions available for diversion. In light of such stimulant abuse, this paper considers four potential solutions for reducing overprescription: (1) decreasing stimulant drug production quotas; (2) changing stimulant drug labeling; (3) monitoring physician prescribing via state prescription drug monitoring programs; and (4) restricting the speech of external actors, such as school personnel and pharmaceutical companies, who may pressure parents to seek medication for their children. After evaluating and rejecting each of these approaches, two alternative strategies for reducing overprescription of stimulant drugs are offered: (1) conducting research investigating the practical problems physicians face when evaluating patients for ADHD and, then, incorporating the insights gleaned into educational efforts and (2) promoting more active leadership and oversight by state medical associations and boards. To provide a background for discussing overprescription, stimulant abuse, and possible remedies, the paper begins reviewing Attention Deficit/Hyperactivity Disorder, the practice of treating the disorder with prescription stimulants, and the import of stimulant drugs being Schedule II controlled substances. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject ritalin en
dc.subject ADHD en
dc.subject stimulants en
dc.subject overprescription en
dc.title Through the Correct Lens: Understanding Overprescription of Stimulant Drugs, Their Abuse, and Where the Remedies Lie en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-15T20:14:59Z

Files in this item

Files Size Format View
Lombardo.pdf 730bytes PDF View/Open
Lombardo.rtf 348.9Kb RTF file View/Open
Lombardo.html 269.7Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters